Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 9Unknown 4Not yet recruiting 3Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Pancreatic Neoplasms 1Clinical Stage III Esophageal Adenocarcinoma AJCC v8 1

Interventions

Fluorouracil 51Oxaliplatin 49Gemcitabine 47Leucovorin 41Capecitabine 35Bevacizumab 29Irinotecan 25Cisplatin 22Radiotherapy 18Radiosurgery 18pembrolizumab 16Nivolumab 16Cetuximab 15Taxes 14Sorafenib 14Paclitaxel 13Biopsy 13Surgical Procedures, Operative 12Drug Therapy 11atezolizumab 10Radiation 10Albumin-Bound Paclitaxel 10lenvatinib 9durvalumab 9Magnetic Resonance Spectroscopy 9Folfox protocol 9Cyclophosphamide 9130-nm albumin-bound paclitaxel 9spartalizumab 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Dietary Supplements × Gastrointestinal × Clear all
NCT02745197 2024-09-19

A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer

University of Alberta

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT04029857 2024-02-13

Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Gastrointestinal

Clinical Stage III Esophageal Adenocarcinoma AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡